From owner-freebsd-chat Thu Oct 11 3:22:16 2001 Delivered-To: freebsd-chat@freebsd.org Received: from nef.ens.fr (nef.ens.fr [129.199.96.32]) by hub.freebsd.org (Postfix) with ESMTP id 7824F37B405 for ; Thu, 11 Oct 2001 03:22:10 -0700 (PDT) Received: from corto.lpt.ens.fr (corto.lpt.ens.fr [129.199.122.2]) by nef.ens.fr (8.10.1/1.01.28121999) with ESMTP id f9BAM5N26248 ; Thu, 11 Oct 2001 12:22:06 +0200 (CEST) Received: from (rsidd@localhost) by corto.lpt.ens.fr (8.9.3/jtpda-5.3.1) id MAA20877 ; Thu, 11 Oct 2001 12:22:05 +0200 (CEST) Date: Thu, 11 Oct 2001 12:22:05 +0200 From: Rahul Siddharthan To: Terry Lambert Cc: cjclark@alum.mit.edu, Salvo Bartolotta , Ted Mittelstaedt , "P. U. (Uli) Kruppa" , freebsd-chat@FreeBSD.ORG Subject: Re: Use of the UNIX Trademark Message-ID: <20011011122205.D17422@lpt.ens.fr> Mail-Followup-To: Terry Lambert , cjclark@alum.mit.edu, Salvo Bartolotta , Ted Mittelstaedt , "P. U. (Uli) Kruppa" , freebsd-chat@FreeBSD.ORG References: <000601c15084$87edd360$1401a8c0@tedm.placo.com> <1002663600.3bc36eb096ee5@webmail.neomedia.it> <20011009231343.C387@blossom.cjclark.org> <1002731960.3bc479b899603@webmail.neomedia.it> <20011010140126.M387@blossom.cjclark.org> <20011010233539.G83192@lpt.ens.fr> <3BC53F53.967C60E7@mindspring.com> <20011011095336.A475@lpt.ens.fr> <3BC5592C.1E8734F6@mindspring.com> Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Disposition: inline User-Agent: Mutt/1.2.5i In-Reply-To: <3BC5592C.1E8734F6@mindspring.com>; from tlambert2@mindspring.com on Thu, Oct 11, 2001 at 01:32:44AM -0700 X-Operating-System: FreeBSD 3.4-STABLE i386 Sender: owner-freebsd-chat@FreeBSD.ORG Precedence: bulk List-ID: List-Archive: (Web Archive) List-Help: (List Instructions) List-Subscribe: List-Unsubscribe: X-Loop: FreeBSD.org Terry Lambert said on Oct 11, 2001 at 01:32:44: > > You need to check the money trail. MIT has an absolutely > *huge* patent portfolio, and gets not an insignificant amount > of its funding from patent licenses. Last I heard, it was > in the tens of billions, and that was 5 years ago. I'm not sure of the numbers, but in the "boom years" after the war, universities got much of their funding from the government: some from the NSF, some from places like NASA. It was driven by technological competition with the USSR, and by military desires (the development of the atomic bomb convinced many that theoretical physics was the way to go...) but whatever the motivations, it had a good effect, for US industry in particular. The funding didn't conflict with the idea that university research is for the public good and should not be appropriated for private profit. Today, that idea is indeed being questioned more and more, but I'd find it quite distressing if universities started regarding patent portfolios as more important than sharing of knowledge. > The transistor was never patented; this is because it was > disclosed more than a year before anyone thought it might > end up being anything more than a curiosity. Bell Labs > has done a lot of that sort of thing. And you can argue that the benefits have been immense. Because the transistor was never patented, it was picked up and played with everywhere, especially by the Japanese. Bell Labs didn't really lose much either: they got a Nobel, fame, etc. If they had tried to hold tightly to their invention, they may have got a few royalties, but the uses to which it was put within the next decade would probably not have materialised so quickly. My point of view is this: when a company develops a new innovation, it *already* has an advantage over its competitors; it can be first to market, it can strengthen its brand image, it can stay ahead of its competitors. However, with strong patent protection, the company can rest on its patents and try to earn revenues by squeezing the rest of the world (like Rambus tried, unsuccessfully, to do). Without patent protection, it will feel the pressure to continue innovating; but if it continues innovating, its brand image will only improve. Most people will be willing to pay 2 or 3 times as much for Glaxo or Pfizer than for a generic knockoff. But if the factor is 200 or 300, rather than 2 or 3, that's a different matter altogether. People continued to buy Intel even though AMD's products were cheaper and performed better. Compare with food products: people buy Kelloggs, or Kraft, for the brand name, not because of superior quality. There is no patent or other IP protection for cheese or corn flakes. R To Unsubscribe: send mail to majordomo@FreeBSD.org with "unsubscribe freebsd-chat" in the body of the message